BS ISO 20397-2:2021
$142.49
Biotechnology. Massively parallel sequencing – Quality evaluation of sequencing data
Published By | Publication Date | Number of Pages |
BSI | 2021 | 30 |
This document specifies general requirements and recommendations for quality assessments and control of massively parallel sequencing (MPS) data. It covers post raw data generation procedures, sequencing alignments, and variant calling.
This document also gives general guidelines for validation and documentation of MPS data.
This document does not apply to any processes related to de novo assembly.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | National foreword |
6 | Foreword |
7 | Introduction |
9 | 1 Scope 2 Normative references 3 Terms and definitions |
14 | 4 Raw data 4.1 General 4.2 Raw data file 4.3 Quality assessment of raw data 4.3.1 General |
15 | 4.3.2 Basic statistics 4.3.3 Quality metrics |
16 | 4.4 Raw data pre-processing 5 Sequence alignment and mapping 5.1 General |
17 | 5.2 Alignment and mapping file format 5.3 Quality control of sequencing alignment and mapping 5.3.1 Basic alignment statistics |
18 | 5.3.2 Quality indicators |
19 | 5.3.3 Methods for alignment and mapping quality assessment 5.4 Alignment post-processing 6 Variant calling 6.1 General 6.2 Data file for variant calling |
20 | 6.3 Quality metrics in the variant calling 6.4 Processing of false positive variants 6.5 Sequence annotation 7 Validation 7.1 General |
21 | 7.2 Validation of quality metrics |
22 | 8 Documentation |
23 | Annex A (informative) Quality metrics for specific example MPS platforms |
24 | Annex B (informative) Coverage and read recommendations by applications |
26 | Annex C (informative) Software for sequence alignment and mapping |
27 | Bibliography |